Myeloma Paper of the Day, July 27th, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Study of molecular mechanisms promoting long-term cytopenia post-BCMA CAR-T therapy suggests CAR-T activation negatively influences hematopoietic stem cell differentiation through paracrine effects leading to HSPC maturation arrest.”
Source: Robert Orlowski/X
Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple Myeloma
Authors: Maria Luisa Palacios-Berraquero, Paula Rodriguez-Marquez, Maria Erendira Calleja-Cervantes, Nerea Berastegui, Aintzane Zabaleta, Leire Burgos, Diego Alignani, Patxi San Martín-Úriz, Amaia Vilas-Zornoza, Saray Rodriguez-Diaz, Susana I Inoges, Ascensión López-Diaz-de-Cerio, Sofia Huerga, Luis Esteban Tamariz-Amador, Jose J Rifon, Ana Alfonso-Pierola, Juan Jose Lasarte, Bruno Paiva, Mikel Hernaez, Paula Rodriguez-Otero, Jesús F. San-Miguel, Teresa Ezponda, Juan Roberto Rodriguez-Madoz and Felipe Prosper
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023